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investigating where these type 2 originate from, we discovered
chondrogenic progenitor cells in OA tissue.
Methods: With the help of cell culture, in situ-hybridization,
immunohistochemistry, Western blot, real time RT-PCR, micro
array and FACS we have characterized the two cell types, as
well as progenitor cells from human OA tissue in vivo and in
vitro.
Results: In vivo, type 1 and type 2 cells show a fibroblast-like
expression pattern with collagen type II and type I synthesis.
Type 2 cells exhibit a faster re-differentiation in 3D alginate cul-
ture. This is indicated by an increased collagen type II expression
already after one week, as well as increased amounts of sox-9. A
subpopulation of type 2 cells also found in OA cartilage consists
of progenitor cells positive for so-called stem cell markers, e.g.
CD105, CD73 or STRO-1 with unregulated PTHrP receptor, up-
regulated RANTES and ADAM-TS5 and lower expression values
for sox-9 than in type 2 cells. Depending on the substrate (colla-
gen, fibronectin or Matrigel) on which they have been grown and
depending on the gender of the patients, these progenitor cells
exhibit a strong interindividual regulation, for example, of colla-
gen type I, fibronectin and integrin alpha 5. In contrast, collagen
type II, sox-9 and COMP remain unregulated. However, they can
be differentiated into osteoblasts, adipocytes and chondrocytes
in vitro.
Conclusions: Due to their OA origin, the type 1 cells remain dis-
eased chondrocytes even without any pathological OA influences
in 3D culture. The re-differentiation efforts of the type 2 cells lead
to a more chondrogenic expression pattern in comparison to their
in vivo status. This shows a more flexible adaptation to changing
environmental conditions and, therefore, they behave more like
progenitor cells.
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Purpose: The prospect of isolating mesenchymal stem cells
(MSC) and culturing these cells into a biomaterial for transplan-
tation into the same patient provides viable option for cartilage
repair. In this study we used our previously described suspen-
sion culture model using poly-HEMA coated plates. We tested
the hypothesis that MSC can differentiate into chondrocytes in
our suspension culture model and that early passage MSCs have
a greater ability to undergo chondrogenesis.
Methods: "Low passage" cells (p3) were isolated and expanded
on adherent flasks for six weeks; "high passage" cells (p9) were
isolated and expanded on adherent 75cm2 flasks for several
months. These cultures were kept in control or chondrogenic
medium (CM). In suspension culture cells self-aggregate. Cells
in each culture type were maintained in DMEM with 10% FBS
or CM (DMEM with 10 μl/mL ITS+premix, 50μg/mL ascorbic
acid, 40μg/mL proline, 10ng/mLTGF-β, and 0.1μM dexametha-
sone). Real-time PCR was performed in triplicate using iQ SYBR
Green, Genes: CD44, collagen types I (CI) and II (CII), aggrecan,
perlecan, decorin, MMP3, MMP13, ADAMTS5, and GAP.
Results: Control biomasses averaged 0.9ug each while those
in CM averaged 7.5ug each. DNA content for the chondrogenic
group was double the control. This suggests that the eight-fold
increase in weight is due more to substantial ECM production
and hydration of ECM components than proliferation. After three
weeks of CM culturing, in suspension culture C II was over 600
fold higher than the control. However, CII expression stayed the
same in suspension cultures after one week of culturing in CM.
Adherent cultures increased in response to ∼70 fold. Western
blot confirmed the presence of CII in the three week cultured
MSCs; the control showed no CII at the protein level. Interestingly,
p9 cells showed a higher CII relative mRNA expression before
the culturing began. These p9 MSCs showed no change in
expression with different culture conditions.
CM decreased CI expression in p3 suspension culture MSCs
but the opposite effect was observed in adherent cultures. CI
was expressed in p9 cells the relative expression did not change
significantly in comparison. CD44 was examined since its expres-
sion can indicate a normal chondrocyte phenotype. P3 adherent
cultured MSCs in CM decreased expression of CD44. However,
CM increased CD44 expression when cultured in suspension
culture. With longer culture time in CM expression of MMP13
becomes much lower as CI and CII expression dramatically in-
creases (in CM). In p3 cells, both aggrecan and ADAMTS-5
expression increases in CM suspension culture at one week
however, when cultured for three weeks, ADAMTS-5 expression
decreases and aggrecan expression remains 5-fold higher than
the control. This supports an initial remodeling of ECM compo-
nents but the overall biosynthesis is towards the formation of
the ECM. Aggrecan is downregulated by CM on adherent plates,
suggesting suspension culture is more conducive to chondroge-
nesis. P9 MSCs do not significantly alter aggrecan or ADAMTS-5
expression with culture or medium
Conclusions: P9 MSC show little ability to alter their phenotype
in comparison to p3 MSCs. Suspension culture initially appears
to inhibit differentiation however this conclusion is misleading and
this culture condition is optimal for the promotion of chondroge-
nesis. It is likely that duration of culture is more important to
see change because of the architectural differences between an
adherent monolayer and a biomass. One week in culture seems
to show the cells in a transitional stage, however longer time in
culture show increased cartilage markers suggesting this may be
a novel approach to engineering cartilage-like material.
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Purpose: Damage to Hyaline cartilage in a large weight bear-
ing joint caused by either trauma or primary focal degenerative
changes (OA), if not treated, can lead to damage of the subchon-
dral bone resulting frequently in pain, disability, and sever altered
quality of life. Since cartilage tissue does not heal spontaneously,
joint functional rehabilitation is based various temporary medical
and surgical solutions. We have developed a novel chondrocytes
cell culture originating from porcine cartilage tissue retrieved
from the mandibular condyle of a newborn animal.
Methods: Porcine Chndrocytes, originating from a mandibular
condyle of a new born animal, are a unique source of cartilage
cells.Gradual collagenase seperation yields a homogenous chon-
drocyte population, which unlike other cartilge source-derived
cells preserve the capability of spontanous differentiation into
cartilage forming cells.
Results: Following a short period of intensive proliferation, these
cells start to differentiate into polygonal shaped cells, expressing
Cbfa1-the skeletal tissues specific transcription factor, type II col-
lagen and cartilage proteoglycan; thus producing ingredients of
genuine hyaline cartilage. The cultured chondrocytes also pre-
serve their responsiveness toward local and systemic regulating
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factors such as growth hormone, insulin, PTH and IGF1. The
primary culture may be split twice without loosing its phenotype,
thus enabling a remarkable cells expansion.
We have shown that maurine and porcine- derived cells injected
into rats’ afflicted (AIA) joints replenish the articular lesion with
typical hyaline cartilage, and with no signs of WBC infiltration.
Since, prior to differentiation, these cells undergo an intensive
proliferation phase, they can also be easily transfected.
We have also shown that osteoprotegerin (OPG)-firstly known for
its activity as RANK ligand decoy receptor, has direct ameliorative
effects on cartilage development. OPG increased proliferation
and differentiation rate of primary chondrocyte culture under
control and catabolic cytokines (IL1 and TNFα)- treated cultures.
Moreover, we have shown that OPG transfected chondrocytes
preserve their typical morphological and functional features.
Conclusions: Therefore, we propose that these primary
spontaneously- differentiating chondrocytes appears to be pro-
genitor cells capable of replenishment of articular lesions and
could also serve as a vehicle for local application of cytokines
like OPG.
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Purpose: The aim of this study was to construct the tissue-
engineering cartilage (TEC) using a bone matrix gelatin (BMG)
scaffold for use in an in vitro cartilage repair model in mature
rabbits.
Methods: Chondrocytes were isolated from articular cartilage
or induced from mesenchymal stem cells (MSCs) harvested
from mature New Zealand white rabbits. The cancellous and
cortical bone BMG scaffold was prepared and chondrocytes
were seeded onto the BMG. The chondrocytes were seeded onto
the cancellous BMG and cultured in vitro for 12 days and then
the complex was implanted into osteochondral cartilage defects
made in the rabbit knee joint. The rabbits were sacrificed at
different time intervals for evaluation of joint function, morphology,
and histological analyses. The TEC was also characterized with
immunohistochemistal and biochemical assays.
Results: After 6 days implantation, 1∼3 cell layers of chondro-
cytes were found to be proliferating on the surface of the BMG
scaffold. After 12 days implantation, the number of chondrocytes
had increase forming a cartilaginous-like tissue of 10∼12 cell
layers with a Safranin-O positive extracellular matrix. After 18
days implantation the neo-cartilage was thicker and immunopos-
itive for type II collagen. After 24∼42 days of implantation, more
cells accumulated forming a repaired cartilage of 25∼30 cell lay-
ers which was Safranin-O and collagen II positive similar to that
seen in articular cartilage. The chondrocytes of neo-cartilaginous
tissue were found to be on the BMG surface and to be in and
around pores of cancellous bone BMG. All rabbits could move
normally within 10 days after the complex was implanted. The
BMG scaffold was resorbed within 8 weeks of implantation. After
24 weeks implantation the cartilage defects were fully repaired
with integrated articular cartilage and subchondral bone. Similar
results were obtained using chondrocytes from MSC expanded
cultures.
Conclusions: The construction of tissue-engineering cartilage
using resorbable BMG scaffolds was successful in producing
tissue engineered cartilage for in vivo transplantation and suc-
cessful repair of osteochondral defects in a rabbit injury model.
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Purpose: In recent years, several clinical studies have suggested
that the local administration of platelet (PLT) derivatives, such as
PLT gel and PLT-rich plasma (PRP), have the potential for a sub-
stantial therapeutic role in tissue regeneration. However, these
studies are often based on anecdotal cases and their results are
sometimes conflicting, highlighting the need for an in-depth anal-
ysis of the complex molecular mechanisms that take part in the
regenerative cellular processes. In this direction, an extensive in
vitro experimentation has been developed, focused on the bio-
logical effects that high concentrated PLT derivatives can exert
on cultured fibroblasts, osteoblasts and chondrocytes. Platelets
are known to actively participate in healing processes by deliv-
ering a broad spectrum of growth factors (GFs) and other active
molecules to the injured site. GFs secreted by platelets syner-
gically act on local cells inducing specific responses: TGF β-I,
PDGF, and IGF-I, promote proliferation, cell migration and syn-
thesis of extracellular matrix, while other released substances,
like VEGF, HGF and bFGF, promote angiogenesis and vasculari-
sation. Articular cartilage is an avascular tissue that has a limited
capacity for self repair. Recently proposed cell-based cartilage
repair procedures require that autolougous articular chondro-
cytes are isolated from a small biopsy, expanded in vitro, and
then either directly injected into the defect or used to engineer
implantable grafts. Several cultural problems, that have limited
the wide clinical application of these techniques, have been ame-
liorated with the introduction of mixtures of recombinant GFs and
the employment of a variety of biocompatible matrices that sup-
port an appropriate tissue formation in vitro and in vivo. Many
GFs are able to induce chondrocyte proliferation and differen-
tiation, but they are quite expensive and their effects strongly
vary in function of their synergy and combination. These cultural
aspects, have suggested the use of concentrated autologous
or homologogous PLT preparations as rich, safe and economic
sources of GFs to be added to cultural medium. The aim of
our study was to demonstrate the mitogenic and differentiating
properties of PRP releasates (PRPr) on human chondrocytes in
mono and three-dimensional cultures.
Methods: In order to assess if PRPr supplementation could
maintain the chondrocyte phenotype or at least inhibit the cell
de-differentiation, we performed time-dependent biochemical and
Real-time PCR gene expression analyses on several cell cultures
independently grown in culture medium with: FCS, human serum
(HS) and PRP and platelet poor plasma (PPP) releasates added
at the same proteic concentration (2 mg/ml).
Results: In comparison with equal amounts of FCS, HS and PPP,
the PRPr was able to enhance the chondrocyte proliferation (up
to 195%) and to increase the expression of Sox9 (about 3 folds),
and Collagen II (2.5 folds) in the first 2 days of culture. Moreover,
an active secretion of proteoglicans was observed, after 20 days
of treatment, only for PRPr-treated cells.
Conclusions: The results of our study support the use of PLT
derivatives for the expansion in culture of fully differentiated
chondrocytes.
